Literature DB >> 28287336

Current outlook of childhood cancer epidemiology in a middle-income country under a public health insurance program.

Roberto Rivera-Luna1, Liliana Velasco-Hidalgo2, Marta Zapata-Tarrés2, Rocío Cárdenas-Cardos3, Marco R Aguilar-Ortiz2.   

Abstract

In Mexico, childhood cancer (0-18 years) is treated in a multidisciplinary way while providing care for more than half of the affected children through a public medical insurance. This insurance is given to all children who do not have any health care coverage in Mexico. This program is offered to the poorest of all Mexicans. All the children with this disease are submitted to pathology diagnosis and treatment according to national treatment protocols from 57 accredited medical institutions. From 2007 to 2015, a total of 24,039 children with cancer have been registered; the male gender predominates by 55%. The highest incidence was in the group aged between 0 and 4 years. Every year, there has been an increment in registration. In 2015, there were 3,433 new patients with an incidence of 150.1/million. In the same year, the incidence for all types of leukemia increased to 89.5/million. But for acute lymphoblastic leukemia, the incidence was found to be 79.8/million, which is extremely high. The mortality rate for all these patients in 2015 was 5.3/100,000. However, with regard to children aged between 15 and 18 years, the mortality rate was 8.5/100,000. Abandonment rate was 10%, and there were nine state institutions that had a mortality rate between 25% and 50% among their patients. Coincidentally, as per the Human Development Index, the parameters for education, health, and income were low for those nine institutions. The purpose of this work is to show the epidemiology and the burden we are facing due to this disease.

Entities:  

Keywords:  Pediatric cancer epidemiology

Mesh:

Year:  2017        PMID: 28287336     DOI: 10.1080/08880018.2016.1276236

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  6 in total

1.  Parent Engagement and Agency in Latin American Childhood Cancer Treatment: A Qualitative Investigation.

Authors:  María Fernanda Olarte-Sierra; Nuria Rossell; Marcela Zubieta; Julia Challinor
Journal:  JCO Glob Oncol       Date:  2020-11

2.  CRLF2 and IKZF1 abnormalities in Mexican children with acute lymphoblastic leukemia and recurrent gene fusions: exploring surrogate markers of signaling pathways.

Authors:  Dafné Moreno Lorenzana; María Del Rocío Juárez Velázquez; Adriana Reyes León; Daniel Martínez Anaya; Adrián Hernández Monterde; Consuelo Salas Labadía; María Del Pilar Navarrete Meneses; Marta Zapata Tarrés; Luis Juárez Villegas; Berenice Jarquín Ramírez; Rocío Cárdenas Cardós; Martha Herrera Almanza; Rogelio Paredes Aguilera; Patricia Pérez Vera
Journal:  J Pathol Clin Res       Date:  2021-04-23

Review 3.  Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia.

Authors:  Silvia Jiménez-Morales; Ivan Sammir Aranda-Uribe; Carlos Jhovani Pérez-Amado; Julian Ramírez-Bello; Alfredo Hidalgo-Miranda
Journal:  Front Immunol       Date:  2021-11-18       Impact factor: 7.561

4.  Characterization of Philadelphia-like Pre-B Acute Lymphoblastic Leukemia: Experiences in Mexican Pediatric Patients.

Authors:  Daniel Martínez-Anaya; Dafné Moreno-Lorenzana; Adriana Reyes-León; Ulises Juárez-Figueroa; Michael Dean; María Montserrat Aguilar-Hernández; Netzi Rivera-Sánchez; Jessica García-Islas; Victoria Vieyra-Fuentes; Marta Zapata-Tarrés; Luis Juárez-Villegas; Rogelio Paredes-Aguilera; Lourdes Vega-Vega; Roberto Rivera-Luna; María Del Rocío Juárez-Velázquez; Patricia Pérez-Vera
Journal:  Int J Mol Sci       Date:  2022-08-24       Impact factor: 6.208

5.  Delivery of Pediatric Cancer Care in Mexico: A National Survey.

Authors:  Laura Rodriguez-Romo; Alberto Olaya Vargas; Sumit Gupta; Jaime Shalkow-Klincovstein; Lourdes Vega-Vega; Alfonso Reyes-Lopez; Carlo Cicero-Oneto; Juan Mejia-Arangure; Oscar Gonzalez-Ramella; Rafael Pineiro-Retif; Aracely Lopez-Facundo; Maria de Los Angeles Del Campo-Martinez; Isidoro Tejocote; Kelly Brennan; Christopher M Booth
Journal:  J Glob Oncol       Date:  2018-07

6.  Transcriptome Analysis Identifies LINC00152 as a Biomarker of Early Relapse and Mortality in Acute Lymphoblastic Leukemia.

Authors:  Diego Alberto Bárcenas-López; Juan Carlos Núñez-Enríquez; Alfredo Hidalgo-Miranda; Fredy Omar Beltrán-Anaya; Didier Ismael May-Hau; Elva Jiménez-Hernández; Vilma Carolina Bekker-Méndez; Janet Flores-Lujano; Aurora Medina-Sansón; Edna Liliana Tamez-Gómez; Víctor Hugo López-García; José Ramón Lara-Ramos; Nora Nancy Núñez-Villegas; José Gabriel Peñaloza-González; Luz Victoria Flores-Villegas; Raquel Amador-Sánchez; Rosa Martha Espinosa-Elizondo; Jorge Alfonso Martín-Trejo; Martha Margarita Velázquez-Aviña; Laura Elizabeth Merino-Pasaye; María Luisa Pérez-Saldívar; David Aldebarán Duarte-Rodríguez; José Refugio Torres-Nava; Beatriz Cortés-Herrera; Karina Anastacia Solís-Labastida; Ana Itamar González-Ávila; Jessica Denisse Santillán-Juárez; Alejandra Jimena García-Velázquez; Haydee Rosas-Vargas; Minerva Mata-Rocha; Omar Alejandro Sepúlveda-Robles; Juan Manuel Mejía-Aranguré; Silvia Jiménez-Morales
Journal:  Genes (Basel)       Date:  2020-03-13       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.